CLINICAL_TRIALS
trial_result
· 2021-05-25
Clinical Trial Update: SGI-110 in Combination With Carboplatin in Ovarian Cancer [Phase 2]
Summary
Results from a Phase 2 trial of SGI-110 (guadecitabine) plus carboplatin in ovarian cancer have been completed and posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Astex Pharmaceuticals, Inc. | Conditions: Ovarian Cancer | Phase 2 | Status: COMPLETED | Results posted: 2021-05-25